Teva Pharm Indus (TEVJF) Net Income by Year
Teva Pharm Indus Ltd reported $1.4B in net income in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Teva Pharm Indus Ltd has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TEVJF Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TEVJF Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Teva Pharm Indus Ltd financials
Frequently Asked Questions
Teva Pharm Indus Ltd reported $1.4B in net income in fiscal year 2025.
Teva Pharm Indus Ltd (TEVJF) reported a $1.6B net loss in fiscal year 2024 and $1.4B in net income in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 15 fiscal years this page covers, Teva Pharm Indus Ltd (TEVJF) net income went from $2.8B in fiscal year 2011 to $1.4B in fiscal year 2025.
Teva Pharm Indus Ltd (TEVJF) reported -$576.0M in net income in Q2 2026. This represents a decrease of 304.3% from the same quarter a year earlier.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Teva Pharm Indus Ltd (TEVJF) reported on that line in every period on record.